Lasers in the Treatment of Nonmelanoma Skin Cancer

被引:24
作者
Choudhary, Sonal [1 ]
Tang, Jennifer [1 ]
Elsaie, Mohamed L. [1 ,2 ]
Nouri, Keyvan [1 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA
[2] Natl Res Ctr, Dept Dermatol & Venerol, Cairo, Egypt
关键词
CARBON-DIOXIDE LASER; BASAL-CELL CARCINOMA; PULSED DYE-LASER; TOPICAL 5-AMINOLEVULINIC ACID; MOHS MICROGRAPHIC SURGERY; ERBIUM-YAG LASER; DELTA-AMINOLEVULINIC-ACID; PHOTOAGED FACIAL SKIN; PHOTODYNAMIC THERAPY; BOWENS-DISEASE;
D O I
10.1111/j.1524-4725.2011.01928.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND Nonmelanoma skin cancers (NMSCs) constitute the largest proportion of cancers worldwide, especially in the Western population, making it essential to develop methods to manage these cancers. Ultraviolet (UV) light being the most significant culprit in the development of NMSCs makes the sun-exposed parts of the body, such as face and extremities, the most vulnerable to develop these tumors. Early diagnosis and emphasis on cosmesis are vital while treating them especially, in patients with multiple squamous and basal cell carcinomas. Lasers seem to be a useful therapeutic modality and are being explored to develop them as a tool for treating skin cancers. OBJECTIVE To review the use of lasers in the treatment of NMSCs. METHODS We reviewed articles that involved the use of lasers in the management of NMSCs and prepared a critical analysis of the same. RESULTS AND CONCLUSIONS Lasers as a single modality, as the coherent light source in photodynamic therapy (PDT), or as an adjunct to PDT or other treatment modalities are a potential method of NMSC eradication. Superficial NMSCs and most precancerous cutaneous lesions such as Bowen's disease and actinic keratoses respond best, whereas deeper, more-aggressive NMSCs show poor outcomes with laser treatments.
引用
收藏
页码:409 / 425
页数:17
相关论文
共 116 条
[1]  
*3M PHARM, 2004, ALD IM CRE 5 PACK IN
[2]  
Adams E L, 1979, J Dermatol Surg Oncol, V5, P803
[3]   Pulsed dye laser treatment of superficial basal cell carcinoma: realistic or not? [J].
Allison, KP ;
Kiernan, MN ;
Waters, RA ;
Clement, RM .
LASERS IN MEDICAL SCIENCE, 2003, 18 (02) :125-126
[4]  
Alpsoy Erkan, 1996, Journal of Dermatology (Tokyo), V23, P394
[5]  
Alster Tina S, 2005, J Drugs Dermatol, V4, P35
[6]   TP53 TUMOR-SUPPRESSOR GENE AND SKIN CARCINOGENESIS [J].
BASSETSEGUIN, N ;
MOLES, JP ;
MILS, V ;
DEREURE, O ;
GUILHOU, JJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (05) :S102-S106
[7]   Interventions for basal cell carcinoma of the skin [J].
Bath-Hextall, F. J. ;
Perkins, W. ;
Bong, J. ;
Williams, H. C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)
[8]   The short- and long-term side effects of carbon dioxide laser resurfacing [J].
Bernstein, LJ ;
Kauvar, ANB ;
Grossman, MC ;
Geronemus, RG .
DERMATOLOGIC SURGERY, 1997, 23 (07) :519-525
[9]   Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases [J].
Bianchi, L ;
Orlandi, A ;
Campione, E ;
Angeloni, C ;
Costanzo, A ;
Spagnoli, LG ;
Chimenti, S .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 151 (01) :148-156
[10]  
Bolshakov S, 2003, CLIN CANCER RES, V9, P228